0001618810-23-000002.txt : 20230616 0001618810-23-000002.hdr.sgml : 20230616 20230616135709 ACCESSION NUMBER: 0001618810-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230616 DATE AS OF CHANGE: 20230616 EFFECTIVENESS DATE: 20230616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stroma Medical Corp CENTRAL INDEX KEY: 0001618810 IRS NUMBER: 264608755 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-484488 FILM NUMBER: 231020273 BUSINESS ADDRESS: STREET 1: 30 HUGHES #206 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-207-3312 MAIL ADDRESS: STREET 1: 30 HUGHES #206 CITY: IRVINE STATE: CA ZIP: 92618 D 1 primary_doc.xml X0708 D LIVE 0001618810 Stroma Medical Corp 30 Hughes #206 Irvine CA CALIFORNIA 92618 949-207-3312 DELAWARE Lumineyes, Inc. None Corporation true Afshin Nadershahi c/o Stroma Medical Corporation 30 Hughes #206 Irvine CA CALIFORNIA 92618 Executive Officer Director Promoter Gregg Homer c/o Stroma Medical Corporation 30 Hughes #206 Irvine CA CALIFORNIA 92618 Executive Officer Director Promoter Baseer Khan c/o Stroma Medical Corporation 30 Hughes #206 Irvine CA CALIFORNIA 92618 Director Stephen Slade c/o Stroma Medical Corporation 30 Hughes #206 Irvine CA CALIFORNIA 92618 Director J Andrew Corley c/o Stroma Medical Corporation 30 Hughes #206 Irvine CA CALIFORNIA 92618 Director Other Technology Decline to Disclose 06b false 2021-03-31 false true true Offering of Series B-1 and B-2 ("Series B Preferred Stock") and the underlying shares of Common Stock issuable upon conversion of Series B Preferred Stock. false 0 43747109 39436871 4310238 Items 13(a) and 13(b) include the conversion of outstanding convertible promissory notes in the aggregate amount of $3,368,000 previously reported on a Form D. true 14 144 0 0 0 false Stroma Medical Corp /s/ Afshin Nadershahi Afshin Nadershahi Chief Executive Officer 2023-06-16